M&G plc’s Edwards Lifesciences EW Stock Holding History

M&G plc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,661	Closed	-$373K	–	383
2026 Q1	$373K	Hold	4,661	–	–	﹤0.01%	350
2025 Q4	$396K	Hold	4,661	–	–	﹤0.01%	340
2025 Q3	$364K	Hold	4,661	–	–	﹤0.01%	340
2025 Q2	$364K	Buy	4,661 +39	+0.8%	+$2.91K	﹤0.01%	379
2025 Q1	$333K	Hold	4,622	–	–	﹤0.01%	396
2024 Q4	$342K	Sell	4,622 -4,153	-47%	-$291K	﹤0.01%	397
2024 Q3	$579K	Sell	8,775 -540	-6%	-$39.2K	﹤0.01%	381
2024 Q2	$857K	Buy	9,315 +431	+5%	+$38.2K	﹤0.01%	353
2024 Q1	$853K	Buy	+8,884	New	+$746K	﹤0.01%	348

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

M&G plc's EW Position: Q2 2026 in Review

M&G plc sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 4,661 shares — an estimated $373K sold.

M&G plc first reported a position in EW in Q1 2024 and held it in 9 quarters. The position peaked at $857K in Q2 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

M&G plc reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
M&G plc sold 4,661 Edwards Lifesciences shares in Q2 2026, an estimated $373K.
M&G plc first reported a position in Edwards Lifesciences in Q1 2024 and held it in 9 quarters.
M&G plc's Edwards Lifesciences position peaked at $857K in Q2 2024.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.